Alvotech (Alvotech) Additional Paid-In Capital : $1,726.61 Mil(As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Alvotech Additional Paid-In Capital?

Alvotech's quarterly additional paid-in capital increased from Sep. 2023 ($1,224.84 Mil) to Dec. 2023 ($1,229.69 Mil) and increased from Dec. 2023 ($1,229.69 Mil) to Mar. 2024 ($1,726.61 Mil).

Alvotech's annual additional paid-in capital increased from Dec. 2021 ($1,000.12 Mil) to Dec. 2022 ($1,058.43 Mil) and increased from Dec. 2022 ($1,058.43 Mil) to Dec. 2023 ($1,229.69 Mil).

Alvotech Additional Paid-In Capital Historical Data

The historical data trend for Alvotech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Additional Paid-In Capital Chart

Alvotech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

166.74

1,000.12

1,058.43

1,229.69

Alvotech Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial									1,235.27	1,224.81	1,224.84	1,229.69	1,726.61

Alvotech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Alvotech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Alvotech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Alvotech (Alvotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (NAS:ALVOW) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

ALVO:USA ALVO:Iceland Z45:Germany

Address

9, rue de Bitbourg, Luxembourg, LUX, L-1273

Website

https://www.alvotech.com

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.